Latini, R., Staszewsky, L., Sun, J., Bethel, M., Disertori, M., Haffner, S., . . . McMurray, J. (2013). Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Cytowanie według stylu Chicago (wyd. 17)Latini, R., et al. Incidence of Atrial Fibrillation in a Population with Impaired Glucose Tolerance: The Contribution of Glucose Metabolism and Other Risk Factors. A Post Hoc Analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial. 2013.
Cytowanie według stylu MLA (wyd. 9)Latini, R., et al. Incidence of Atrial Fibrillation in a Population with Impaired Glucose Tolerance: The Contribution of Glucose Metabolism and Other Risk Factors. A Post Hoc Analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial. 2013.